Skip to main content

Table 5 Socioeconomic differences in the utilization of antimalarials by pregnant women

From: Examining equity in access to long-lasting insecticide nets and artemisinin-based combination therapy in Anambra state, Nigeria

Antimalarials used for treatment of fever Q1 (%) Q2 (%) Q3 (%) Q4 (%) Q5 (%) Q1:Q5 Chi square (p value)
Children less than five years        
ACTs 9(28) 13(29) 13(33) 29(43) 27(26) 1.1 5.97(0.20)
Chloroquine 0(0) 1(2) 0(0) 0(0) 2(2) 0 2.85(0.58)
Quinine 0(0) 0(0) 1(2.6) 1(1.5) 1(1) 0 1.83(0.77)
Sulfadoxine-pyrimethamine 7(21) 11(24) 8(21) 13(19) 22(21) 1 0.42(0.98)
Artesunate monotherapy 1(3) 2(4) 5(13) 4(6) 9(9) 0.3 3.69(0.45)
Others 5(15) 4(9) 7(18) 7(10) 6(6) 2.5 5.61(0.23)
Pregnant women for treatment of malaria        
ACTs 10(27) 16(28) 15(34) 36(48) 42(38) 0.71 7.66(0.11)
Chloroquine 0(0) 0(0) 0(0) 0(0) 1(1) 0.0 1.94(0.75)
Quinine 1(3) 0(0) 1(2.3) 1(1.3) 2(2) 1.49 1.45(0.84)
Sulfadoxine-pyrimethamine 10(27) 21(37) 14(32) 16(21) 30(27) 0.99 4.21(0.38)
Artesunate monotherapy 0(0) 1(2) 0(0) 1(1) 1(1) 0.0 1.32(0.86)
Others 10(27) 5(9) 11(25) 12(16) 6(5) 4.95 18.09(0.001)